Eyenovia to End Eye Drug Study After Missing Late-stage Goal, Shares Fall
(Reuters) -Eyenovia will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness in children after it failed to slow the condition's progression, sending its shares down nearly 57% before the bell on Friday …